Tanvi Pandit-Rajani is a recognized thought leader in private sector engagement and market access, with over 20 years of experience shaping policies, forging partnerships, and driving innovative solutions to expand the reach of life-saving health products and services globally. In 2021, she joined Medicines360 as a Board Member of its global subsidiary, Impact RH360, where she provides strategic guidance on contraceptive market access, policy reform, and multi-sector collaboration to advance the organization’s mission.

Throughout her career, Tanvi has led transformative initiatives that have mobilized over $500 million in funding and influenced national policies to expand access to essential medicines and services across more than 10 low- and middle-income countries. Her expertise in market-shaping strategies and public-private partnerships has directly contributed to increasing the availability of critical healthcare, ensuring they reach underserved populations. Her experience spans working with the U.S. government, private sector, and nonprofit organizations, equipping her with a nuanced understanding of how policy, markets, and funding intersect to drive impact.

Tanvi holds an MPH in Global Health from Emory University’s Rollins School of Public Health and a BS in Nutrition from the University of Texas. A firm believer in the power of partnerships, she continues to champion market-driven solutions that bridge the gap between innovation and equitable healthcare access. Through her work at Medicines360, she remains committed to ensuring that women worldwide have reliable, affordable access to contraception to support their health and well-being.